Home » Acadia Pharmaceuticals Announces $36 Million Financing
Acadia Pharmaceuticals Announces $36 Million Financing
April 15, 2005
Acadia Pharmaceuticals, a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, announced that it has entered into a definitive purchase agreement for a $36 million private placement of newly issued shares of common stock and the concurrent issuance of warrants for the purchase of additional shares of common stock. The financing is expected to close on April 20, 2005.
Yahoo News (http://biz.yahoo.com/prnews/050415/laf023.html?.v=6)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct